A Feasibility Study of Cyclophosphamide, Trastuzumab, and an Allogeneic GM-CSF–Secreting Breast Tumor Vaccine for HER2+ Metastatic Breast Cancer
Gang Chen(Fudan University), Leisha A. Emens(Johns Hopkins University), Kellie Hirt(Johns Hopkins University), John H. Fetting(Johns Hopkins University), Justin M. Asquith(Johns Hopkins University), Antonio C. Wolff(Johns Hopkins University), Elizabeth Manning Duus(Johns Hopkins University), Elizabeth Garrett‐Mayer(Novartis (Switzerland)), Saadet Atay-Rosenthal(Johns Hopkins University), Xiaobu Ye(Johns Hopkins University), Marina Laiko(Johns Hopkins University), Elizabeth M. Jaffee(Bloomberg (United States)), Vered Stearns(Johns Hopkins University), Richa Gupta(Johns Hopkins University), Jennifer N. Uram(Johns Hopkins University), Maureen Berg(Johns Hopkins University), James M. Leatherman(Geisinger Medical Center), S. Petrik(Johns Hopkins University), Maithili M. Daphtary(Johns Hopkins University), Nancy E. Davidson(WinnMed), Tianna Dauses(Johns Hopkins University)
Cited by 92
Related Papers
PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
|New England Journal of Medicine|2015|9.4k
American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer
|Journal of Clinical Oncology|2010|4.3k
Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses
|Science|2008|4k
AACR Project GENIE: Powering Precision Medicine through an International Consortium
|Cancer Discovery|2017|2k